E50G (p.Glu50Gly) variant of SGCA (Alpha-sarcoglycan)
E50G (p.Glu50Gly) in SGCA (Alpha-sarcoglycan) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
E50G (p.Glu50Gly) variant details
- p.Glu50Gly
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available